AdventHealth Cancer Institute — Orlando, Florida

AdventHealth Cancer Institute is a clinical research site located in Orlando, Florida, United States 32804.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

AdventHealth Cancer Institute has participated in 25 clinical trials with 15 currently active.

Therapeutic areas: Triple Negative Breast Neoplasms, Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line, Gynecologic Cancer.

Sponsors: Seagen Inc., Bristol-Myers Squibb, Viome.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AdventHealth Cancer Institute?

AdventHealth Cancer Institute has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AdventHealth Cancer Institute conducted?

AdventHealth Cancer Institute has 25 clinical trials on record, with 15 currently active. Their work covers Triple Negative Breast Neoplasms, Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line, Gynecologic Cancer.

Is AdventHealth Cancer Institute accredited by Crixeo Health?

Yes — AdventHealth Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about AdventHealth Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.